Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis.

[1]  E. Oliva,et al.  Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study. , 2013, Gynecologic oncology.

[2]  P. Goodfellow,et al.  Uterine Serous Carcinoma: Increased Familial Risk for Lynch-Associated Malignancies , 2012, Cancer Prevention Research.

[3]  A. Nickles Fader,et al.  Uterine Papillary Serous Carcinoma , 2011, Clinical obstetrics and gynecology.

[4]  L. Massuger,et al.  Clinical management of uterine papillary serous carcinoma , 2011, Expert review of anticancer therapy.

[5]  J. Schorge,et al.  Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. , 2010, Gynecologic oncology.

[6]  Jie Lin,et al.  [Evaluation of two-tier grading system and significance of p53 protein over-expression in ovarian serous carcinoma]. , 2010, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[7]  P. Gehrig,et al.  Uterine papillary serous carcinoma: epidemiology, pathogenesis and management , 2010, Current opinion in obstetrics & gynecology.

[8]  A. Secord,et al.  An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). , 2009, Gynecologic oncology.

[9]  L. Havrilesky,et al.  Platinum/taxane‐based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma , 2009, Cancer.

[10]  A. Malpica.  Grading of ovarian cancer: a histotype-specific approach. , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[11]  Mark F. Munsell,et al.  Interobserver and Intraobserver Variability of a Two-tier System for Grading Ovarian Serous Carcinoma , 2007, The American journal of surgical pathology.

[12]  I. Horkayne-Szakaly,et al.  Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum. , 2006, Gynecologic oncology.

[13]  S. Kalloger,et al.  Description of a Novel System for Grading of Endometrial Carcinoma and Comparison With Existing Grading Systems , 2005, The American journal of surgical pathology.

[14]  Michael T Deavers,et al.  Grading Ovarian Serous Carcinoma Using a Two-Tier System , 2004, The American journal of surgical pathology.

[15]  R. Kurman,et al.  A Binary Architectural Grading System for Uterine Endometrial Endometrioid Carcinoma Has Superior Reproducibility Compared With FIGO Grading and Identifies Subsets of Advance-Stage Tumors With Favorable and Unfavorable Prognosis , 2000, The American journal of surgical pathology.

[16]  F. Akiyama,et al.  Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system. , 1998, Gynecologic oncology.

[17]  R. Scully,et al.  Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases. , 1995, Gynecologic oncology.

[18]  M. Sherman,et al.  Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features , 1992, The American journal of surgical pathology.

[19]  A. L. Nielsen,et al.  Evaluation of the reproducibility of the revised 1988 international federation of gynecology and obstetrics grading system of endometrial cancers with special emphasis on nuclear grading , 1991, Cancer.

[20]  K. Barwick,et al.  Diffusely Infiltrating Adenocarcinoma of the Endometrium: A Subtype with Poor Prognosis , 1988, The American journal of surgical pathology.

[21]  Mittal Kr,et al.  Diffusely infiltrating adenocarcinoma of the endometrium. A subtype with poor prognosis. , 1988 .

[22]  P. Schwartz,et al.  Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high‐risk and low‐risk groups , 1988, Cancer.

[23]  M. Merino,et al.  Uterine papillary serous carcinoma , 1987, Obstetrics and gynecology.

[24]  R. Kempson,et al.  Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma , 1982, The American journal of surgical pathology.

[25]  Azoury Rs,et al.  The transverse vaginal septum: a clinicopathologic evaluation. , 1979 .

[26]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[27]  Sun Li-ping.  Uterine papillary serous carcinoma:a clinicopathological study of 24 cases , 2006 .

[28]  S. Silverberg.  Toward the development of a universal grading system for ovarian epithelial carcinoma. , 1999, Gynecologic oncology.

[29]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.